Powder: -20°C for 3 years | In solvent: -80°C for 1 year
CGP78850 is a potent and selective Grb2 SH2-phosphopeptide interaction antagonist that holds potential for cancer research.
Pack Size | Availability | Price/USD | Quantity |
---|---|---|---|
25 mg | Inquiry | $ 1,520.00 |
Description | CGP78850 is a potent and selective Grb2 SH2-phosphopeptide interaction antagonist that holds potential for cancer research. |
In vitro | CGP78850 (0~100 μM; 90 minutes; MDA-MB-468 cells) demonstrates a dose-dependent reduction in Grb2 protein association, inhibiting interactions between epidermal growth factor receptor (EGFR) and Grb2 as well as between Shc and Grb2 in living cells. Additionally, it effectively prevents MDA-MB-468 cells from forming colonies in soft agar in a dose-dependent manner. Western Blot Analysis further confirms these effects, showing a significant decrease in Grb2 protein levels in MDA-MB-468 cells treated with varying concentrations (0~100 μM) over a 90-minute period. |
Molecular Weight | 723.764 |
Formula | C36H46N5O9P |
CAS No. | 258326-83-9 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
CGP78850 258326-83-9 CGP-78850 CGP 78850 inhibitor inhibit